{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T04:30:55Z","timestamp":1775190655349,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10241-8","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T16:09:12Z","timestamp":1737216552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Targeted apoptosis in breast cancer cells via niosome-mediated delivery of cyclophosphamide and sodium oxamate"],"prefix":"10.1007","volume":"52","author":[{"given":"Mahsa","family":"Fakeri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8400-4209","authenticated-orcid":false,"given":"Mehdi","family":"Haghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5119-252X","authenticated-orcid":false,"given":"Rana","family":"Jahanban Esfahlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marziyeh","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ali","family":"Hosseinpour Feizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"issue":"3","key":"10241_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP (2019) Breast cancer treatment: a review. JAMA 321(3):288\u2013300","journal-title":"JAMA"},{"key":"10241_CR2","first-page":"227","volume":"5","author":"RJ Esfahlan","year":"2011","unstructured":"Esfahlan RJ, Zarghami N, Esfahlan AJ, Mollazadeh M, Nejati K, Nasiri M (2011) The possible impact of obesity on androgen, progesterone and estrogen receptors (ERalpha and ERbeta) gene expression in breast cancer patients. Breast Cancer\u202f: Bas Clin Res 5:227\u2013237","journal-title":"Breast Cancer : Bas Clin Res"},{"issue":"3","key":"10241_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020 GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin 71(3):209\u2013249","journal-title":"CA: A Cancer J Clin"},{"key":"10241_CR4","doi-asserted-by":"publisher","first-page":"104354","DOI":"10.1016\/j.jddst.2023.104354","volume":"82","author":"H Dadashi","year":"2023","unstructured":"Dadashi H, Eskandani M, Roshangar L, Sharifi-Azad M, Shahpouri M, Cho WC et al (2023) Remotely-controlled hydrogel platforms for recurrent cancer therapy. J Drug Deliv Sci Technol 82:104354","journal-title":"J Drug Deliv Sci Technol"},{"key":"10241_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jconrel.2023.09.029","volume":"363","author":"A Doustmihan","year":"2023","unstructured":"Doustmihan A, Fathi M, Mazloomi M, Salemi A, Hamblin MR, Jahanban-Esfahlan R (2023) Molecular targets, therapeutic agents and multitasking nanoparticles to deal with cancer stem cells: a narrative review. J Control Release 363:57\u201383","journal-title":"J Control Release"},{"key":"10241_CR6","doi-asserted-by":"publisher","first-page":"116951","DOI":"10.1016\/j.biopha.2024.116951","volume":"177","author":"S Alimohammadvand","year":"2024","unstructured":"Alimohammadvand S, KavehZenjanab M, Mashinchian M, Shayegh J, Jahanban-Esfahlan R (2024) Recent advances in biomimetic cell membrane\u2013camouflaged nanoparticles for cancer therapy. Biomed Pharmacother 177:116951","journal-title":"Biomed Pharmacother"},{"key":"10241_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jconrel.2019.10.003","volume":"315","author":"A Jahanban-Esfahlan","year":"2019","unstructured":"Jahanban-Esfahlan A, Seidi K, Jaymand M, Schmidt TL, Zare P, Javaheri T et al (2019) Dynamic DNA nanostructures in biomedicine: beauty, utility and limits. J Contr Release 315:166\u2013185","journal-title":"J Contr Release"},{"issue":"45","key":"10241_CR8","doi-asserted-by":"publisher","first-page":"2104123","DOI":"10.1002\/adfm.202104123","volume":"30","author":"M Niazi","year":"2021","unstructured":"Niazi M, Alizadeh E, Zarebkohan A, Seidi K, Ayoubi-Joshaghani MH, Azizi M et al (2021) Advanced bioresponsive multitasking hydrogels in the new era of biomedicine. Adv Func Mater 30(45):2104123","journal-title":"Adv Func Mater"},{"key":"10241_CR9","doi-asserted-by":"publisher","first-page":"105567","DOI":"10.1016\/j.jddst.2024.105567","volume":"95","author":"M KavehZenjanab","year":"2024","unstructured":"KavehZenjanab M, Alimohammadvand S, Doustmihan A, Kianian S, SadeghzadehOskouei B, Mazloomi M et al (2024) Paclitaxel for breast cancer therapy: a review on effective drug combination modalities and nano drug delivery platforms. J Drug Deliv Sci Technol 95:105567","journal-title":"J Drug Deliv Sci Technol"},{"key":"10241_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02605-y","author":"MF Masoumeh Sharifi-Azad","year":"2022","unstructured":"Masoumeh Sharifi-Azad MF, Cho WC, Barzegari A, Dadashi H, Dadashpour M, Jahanban-Esfahlan R (2022) Recent advances in targeted drug delivery systems for resistant colorectal cancer. Cancer Cell Int. https:\/\/doi.org\/10.1186\/s12935-022-02605-y","journal-title":"Cancer Cell Int"},{"key":"10241_CR11","doi-asserted-by":"publisher","first-page":"100672","DOI":"10.1016\/j.mtbio.2023.100672","volume":"20","author":"M Azizi","year":"2023","unstructured":"Azizi M, Jahanban-Esfahlan R, Samadian H, Hamidi M, Seidi K, Dolatshahi-Pirouz A et al (2023) Multifunctional nanostructures: intelligent design to overcome biological barriers. Mater Today Bio 20:100672","journal-title":"Mater Today Bio"},{"issue":"1","key":"10241_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","volume":"18","author":"R Baghban","year":"2020","unstructured":"Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M et al (2020) Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal 18(1):59","journal-title":"Cell Commun Signal"},{"key":"10241_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138418","author":"H Dadashi","year":"2025","unstructured":"Dadashi H, Mashinchian M, Karimian-Shaddel A, Mohabbat A, Vandghanooni S, Eskandani M et al (2025) Chitosan nanoparticles loaded with metformin and digoxin synergistically inhibit MCF-7 breast cancer cells through suppression of NOTCH-1 and HIF-1\u03b1 gene expression. Int J Biol Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138418","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"10241_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12668-024-01647-y","volume":"15","author":"Z Hashemi","year":"2024","unstructured":"Hashemi Z, Beheshtizadeh N, Jaymand M, Jahanban-Esfahlan A, Akbari M, Jahanban ER (2024) Engineered niosomes for cancer therapy: classification, synthesis, and clinical applications. BioNanoScience 15(1):34","journal-title":"BioNanoScience"},{"issue":"9","key":"10241_CR15","doi-asserted-by":"publisher","first-page":"10875","DOI":"10.1021\/acsomega.3c09782","volume":"9","author":"M KavehZenjanab","year":"2024","unstructured":"KavehZenjanab M, Abdolahinia ED, Alizadeh E, Hamishehkar H, Shahbazi R, Ranjbar-Navazi Z et al (2024) Hyaluronic acid-targeted niosomes for effective breast cancer chemostarvation therapy. ACS Omega 9(9):10875\u201310885","journal-title":"ACS Omega"},{"issue":"5","key":"10241_CR16","doi-asserted-by":"publisher","first-page":"055015","DOI":"10.1088\/1748-605X\/ad5d9b","volume":"19","author":"M Sharifi-Azad","year":"2024","unstructured":"Sharifi-Azad M, KavehZenjanab M, Shahpouri M, Adili-Aghdam MA, Fathi M, Jahanban-Esfahlan R (2024) Codelivery of methotrexate and silibinin by niosome nanoparticles for enhanced chemotherapy of CT26 colon cancer cells. Biomed Mater 19(5):055015","journal-title":"Biomed Mater"},{"issue":"2S","key":"10241_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.22270\/jddt.v12i2-S.5264","volume":"12","author":"R Sharma","year":"2022","unstructured":"Sharma R, Dua JS, Parsad DN (2022) An overview on Niosomes: Novel Pharmaceutical drug delivery system. J. Drug Deliv Therapeut 12(2S):171\u2013177","journal-title":"J. Drug Deliv Therapeut"},{"issue":"3","key":"10241_CR18","doi-asserted-by":"publisher","first-page":"035015","DOI":"10.1088\/1748-605X\/ad2ed5","volume":"19","author":"MK Zenjanab","year":"2024","unstructured":"Zenjanab MK, Pakchin PS, Fathi M, Abdolahinia ED, Adibkia K (2024) Niosomes containing paclitaxel and gold nanoparticles with different coating agents for efficient chemo\/photothermal therapy of breast cancer. Biomed Mater 19(3):035015","journal-title":"Biomed Mater"},{"issue":"1","key":"10241_CR19","doi-asserted-by":"publisher","first-page":"27380","DOI":"10.1038\/s41598-024-78817-1","volume":"14","author":"R Shahbazi","year":"2024","unstructured":"Shahbazi R, Mirjafary Z, Zarghami N, Saeidian H (2024) Efficient PEGylated magnetic nanoniosomes for co-delivery of artemisinin and metformin: a new frontier in chemotherapeutic efficacy and cancer therapy. Sci Rep 14(1):27380","journal-title":"Sci Rep"},{"issue":"1","key":"10241_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13058-018-1012-0","volume":"20","author":"M-B Jensen","year":"2018","unstructured":"Jensen M-B, L\u00e6nkholm A-V, Nielsen TO, Eriksen JO, Wehn P, Hood T et al (2018) The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer. Breast Cancer Res 20(1):79","journal-title":"Breast Cancer Res"},{"issue":"14","key":"10241_CR21","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.7314\/APJCP.2015.16.14.5703","volume":"16","author":"A Jahanban-Esfahlan","year":"2015","unstructured":"Jahanban-Esfahlan A, Modaeinama S, Abasi M, MesgariAbbasi M, Jahanban-Esfahlan R (2015) Anti proliferative properties of Melissa Officinalis in different human cancer cells. Asian Pac J Cancer Prev 16(14):5703\u20135707","journal-title":"Asian Pac J Cancer Prev"},{"key":"10241_CR22","doi-asserted-by":"publisher","first-page":"172593","DOI":"10.1016\/j.ejphar.2019.172593","volume":"861","author":"M Sucic","year":"2019","unstructured":"Sucic M, Luetic K, Jandric I, Drmic D, Sever AZ, Vuletic LB et al (2019) (2019) Therapy of the rat hemorrhagic cystitis induced by cyclophosphamide Stable gastric pentadecapeptide BPC 157 L-arginine L-NAME. Eur J Pharm 861:172593","journal-title":"Eur J Pharm"},{"issue":"10","key":"10241_CR23","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1016\/j.bioactmat.2021.03.003","volume":"6","author":"F Yang","year":"2021","unstructured":"Yang F, Shi K, Hao Y, Jia Y, Liu Q, Chen Y et al (2021) Cyclophosphamide loaded thermo-responsive hydrogel system synergize with a hydrogel cancer vaccine to amplify cancer immunotherapy in a prime-boost manner. Bioactive materials 6(10):3036\u20133048","journal-title":"Bioactive materials"},{"key":"10241_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.839464","author":"H Shi","year":"2022","unstructured":"Shi H, Hou B, Li H, Zhou H, Du B (2022) Cyclophosphamide Induces the Ferroptosis of Tumor Cells Through Heme Oxygenase-1. Front Pharm. https:\/\/doi.org\/10.3389\/fphar.2022.839464","journal-title":"Front Pharm"},{"issue":"2","key":"10241_CR25","doi-asserted-by":"publisher","first-page":"R227","DOI":"10.1152\/ajpregu.00226.2022","volume":"324","author":"H-C Shen","year":"2023","unstructured":"Shen H-C, Chen Z-Q, Liu X-C, Guan J-F, Xie D-Z, Li Y-Y et al (2023) Sodium oxamate reduces lactate production to improve the glucose homeostasis of Micropterus salmoides fed high-carbohydrate diets. Am J Physiol-Reg, Integrat Comparat Physiol 324(2):R227\u2013R241","journal-title":"Am J Physiol-Reg, Integrat Comparat Physiol"},{"issue":"1","key":"10241_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.canlet.2014.11.046","volume":"358","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Han F, Yang S, Wu J, Zhan W (2015) Oxamate-mediated inhibition of lactate dehydrogenase induces protective autophagy in gastric cancer cells: Involvement of the Akt\u2013mTOR signaling pathway. Cancer Lett 358(1):17\u201326","journal-title":"Cancer Lett"},{"issue":"15","key":"10241_CR27","doi-asserted-by":"publisher","first-page":"7948","DOI":"10.3390\/ijms22157948","volume":"22","author":"E Jamshidifar","year":"2021","unstructured":"Jamshidifar E, EshratiYeganeh F, Shayan M, TavakkoliYaraki M, Bourbour M, Moammeri A et al (2021) Super magnetic niosomal nanocarrier as a new approach for treatment of breast cancer: a case study on SK-BR-3 and MDA-MB-231 cell lines. Int J Mol Sci 22(15):7948","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10241_CR28","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1016\/j.xphs.2019.03.020","volume":"108","author":"P Kulkarni","year":"2019","unstructured":"Kulkarni P, Rawtani D (2019) Application of box-behnken design in the preparation, optimization, and in vitro evaluation of self-assembly\u2013based tamoxifen-and doxorubicin-loaded and dual drug\u2013loaded niosomes for combinatorial breast cancer treatment. J Pharm Sci 108(8):2643\u20132653","journal-title":"J Pharm Sci"},{"key":"10241_CR29","doi-asserted-by":"publisher","first-page":"132940","DOI":"10.1016\/j.ijbiomac.2024.132940","volume":"272","author":"H Mahmudi","year":"2024","unstructured":"Mahmudi H, Shahpouri M, Adili-Aghdam MA, Akbari M, Salemi A, Alimohammadvand S et al (2024) Self-activating chitosan-based nanoparticles for sphingosin-1 phosphate modulator delivery and selective tumor therapy. Int J Biol Macromol 272:132940","journal-title":"Int J Biol Macromol"},{"key":"10241_CR30","doi-asserted-by":"publisher","DOI":"10.34172\/apb.2024.054","author":"S Mohammad","year":"2024","unstructured":"Mohammad S, Mohammed AAA, Hossein M, Saeedeh G, Hamed D, Aysan S, Sajjad A, Leila R, Abolfazl B, Mehdi J, Rana J-E (2024) Dual-stage acting dendrimeric nanoparticle for deepened chemotherapeutic drug delivery to tumor cells. Adv Pharm Bull. https:\/\/doi.org\/10.34172\/apb.2024.054","journal-title":"Adv. Pharm. Bull."},{"key":"10241_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.gene.2017.02.034","volume":"613","author":"R Jahanban-Esfahlan","year":"2017","unstructured":"Jahanban-Esfahlan R, Seidi K, Monfaredan A, Shafie-Irannejad V, Abbasi MM, Karimian A et al (2017) The herbal medicine Melissa officinalis extract effects on gene expression of p53, Bcl-2, Her2, VEGF-A and hTERT in human lung, breast and prostate cancer cell lines. Gene 613:14\u201319","journal-title":"Gene"},{"issue":"14","key":"10241_CR32","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.7314\/APJCP.2015.16.14.5727","volume":"16","author":"B Yousefi","year":"2015","unstructured":"Yousefi B, Abasi M, Abbasi MM, Jahanban-Esfahlan R (2015) Anti-proliferative properties of cornus mass fruit in different human cancer cells. Asian Pac J Cancer Prev 16(14):5727\u20135731","journal-title":"Asian Pac J Cancer Prev"},{"key":"10241_CR33","doi-asserted-by":"publisher","first-page":"1174120","DOI":"10.3389\/fphar.2023.1174120","volume":"14","author":"G Shafiei","year":"2023","unstructured":"Shafiei G, Jafari-Gharabaghlou D, Farhoudi-Sefidan-Jadid M, Alizadeh E, Fathi M, Zarghami N (2023) Targeted delivery of silibinin via magnetic niosomal nanoparticles: potential application in treatment of colon cancer cells. Front Pharmacol 14:1174120","journal-title":"Front Pharmacol"},{"issue":"12","key":"10241_CR34","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1016\/j.apt.2021.10.019","volume":"32","author":"FR Amale","year":"2021","unstructured":"Amale FR, Ferdowsian S, Hajrasouliha S, Kazempoor R, Mirzaie A, Dakkali MS et al (2021) Gold nanoparticles loaded into niosomes: a novel approach for enhanced antitumor activity against human ovarian cancer. Adv Powder Technol 32(12):4711\u20134722","journal-title":"Adv Powder Technol"},{"key":"10241_CR35","doi-asserted-by":"publisher","first-page":"101763","DOI":"10.1016\/j.jddst.2020.101763","volume":"58","author":"DH Khan","year":"2020","unstructured":"Khan DH, Bashir S, Khan MI, Figueiredo P, Santos HA, Peltonen L (2020) Formulation optimization and in vitro characterization of rifampicin and ceftriaxone dual drug loaded niosomes with high energy probe sonication technique. J Drug Del Sci Technol 58:101763","journal-title":"J Drug Del Sci Technol"},{"issue":"8","key":"10241_CR36","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.2174\/1567201813666160328113522","volume":"13","author":"M Thakkar","year":"2016","unstructured":"Thakkar M (2016) Opportunities and challenges for niosomes as drug delivery systems. Curr Drug Deliv 13(8):1275\u20131289","journal-title":"Curr Drug Deliv"},{"issue":"1","key":"10241_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13036-023-00375-3","volume":"17","author":"A Bakand","year":"2023","unstructured":"Bakand A, Moghaddam SV, Naseroleslami M, Andr\u00e9 H, Mousavi-Niri N, Alizadeh E (2023) Efficient targeting of HIF-1\u03b1 mediated by YC-1 and PX-12 encapsulated niosomes: potential application in colon cancer therapy. J Biol Eng 17(1):58","journal-title":"J Biol Eng"},{"issue":"Suppl2","key":"10241_CR38","first-page":"1","volume":"17","author":"F Nowroozi","year":"2018","unstructured":"Nowroozi F, Almasi A, Javidi J, Haeri A, Dadashzadeh S (2018) Effect of surfactant type, cholesterol content and various downsizing methods on the particle size of niosomes. Iranian J Pharm Res: IJPR 17(Suppl2):1","journal-title":"Iranian J Pharm Res: IJPR"},{"issue":"45","key":"10241_CR39","doi-asserted-by":"publisher","first-page":"13379","DOI":"10.1021\/acs.langmuir.1c02056","volume":"37","author":"DJ Pochapski","year":"2021","unstructured":"Pochapski DJ, Carvalho dos Santos C, Leite GW, Pulcinelli SH, Santilli CV (2021) Zeta potential and colloidal stability predictions for inorganic nanoparticle dispersions: Effects of experimental conditions and electrokinetic models on the interpretation of results. Langmuir 37(45):13379\u201313389","journal-title":"Langmuir"},{"key":"10241_CR40","doi-asserted-by":"publisher","first-page":"100349","DOI":"10.1016\/j.mtbio.2022.100349","volume":"16","author":"A Mansoori-Kermani","year":"2022","unstructured":"Mansoori-Kermani A, Khalighi S, Akbarzadeh I, Niavol FR, Motasadizadeh H, Mahdieh A et al (2022) Engineered hyaluronic acid-decorated niosomal nanoparticles for controlled and targeted delivery of epirubicin to treat breast cancer. Mater Today Bio 16:100349","journal-title":"Mater Today Bio"},{"issue":"1","key":"10241_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12645-024-00252-8","volume":"15","author":"M Safari Sharafshadeh","year":"2024","unstructured":"Safari Sharafshadeh M, Tafvizi F, Khodarahmi P, Ehtesham S (2024) Folic acid-functionalized PEGylated niosomes co-encapsulated cisplatin and doxoribicin exhibit enhanced anticancer efficacy. Cancer Nanotechnol 15(1):14","journal-title":"Cancer Nanotechnol"},{"issue":"9","key":"10241_CR42","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1016\/j.apt.2020.08.011","volume":"31","author":"I Akbarzadeh","year":"2020","unstructured":"Akbarzadeh I, TavakkoliYaraki M, Ahmadi S, Chiani M, Nourouzian D (2020) Folic acid-functionalized niosomal nanoparticles for selective dual-drug delivery into breast cancer cells: an in-vitro investigation. Adv Powder Technol 31(9):4064\u20134071","journal-title":"Adv Powder Technol"},{"key":"10241_CR43","first-page":"1","volume":"11","author":"G John","year":"2021","unstructured":"John G, Sinha P, Rathnam G, Ubaidulla U, Aravind R (2021) A review on future prospects of niosomes towards drug delivery applications. IOSR J Pharm 11:1\u20139","journal-title":"IOSR J Pharm"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10241-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10241-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10241-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:38:38Z","timestamp":1766853518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10241-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10241"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10241-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that there are no known conflicts of interest associated with this publication, and there has been no significant financial support for this work that could have influenced its outcome.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"139"}}